Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

September 16, 2016

Primary Completion Date

August 18, 2018

Study Completion Date

February 14, 2020

Conditions
Endometrial Endometrioid AdenocarcinomaEndometrial Mixed Cell AdenocarcinomaEndometrial Serous AdenocarcinomaEndometrial Undifferentiated CarcinomaMetastatic Endometrioid AdenocarcinomaRecurrent Uterine Corpus Cancer
Interventions
DRUG

Copanlisib

Given IV

OTHER

Laboratory Biomarker Analysis

Correlative studies

Trial Locations (43)

11203

State University of New York Downstate Medical Center, Brooklyn

14263

Roswell Park Cancer Institute, Buffalo

15232

University of Pittsburgh Cancer Institute (UPCI), Pittsburgh

19104

University of Pennsylvania/Abramson Cancer Center, Philadelphia

22042

Inova Fairfax Hospital, Falls Church

29605

Prisma Health Cancer Institute - Faris, Greenville

29672

Prisma Health Cancer Institute - Seneca, Seneca

30342

Northside Hospital, Atlanta

31405

Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah

33136

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami

33442

UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach

43214

Riverside Methodist Hospital, Columbus

43219

The Mark H Zangmeister Center, Columbus

43560

ProMedica Flower Hospital, Sylvania

43606

ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo

48201

Wayne State University/Karmanos Cancer Institute, Detroit

48334

Weisberg Cancer Treatment Center, Farmington Hills

50309

Iowa Methodist Medical Center, Des Moines

Medical Oncology and Hematology Associates-Des Moines, Des Moines

54449

Marshfield Medical Center-Marshfield, Marshfield

54482

Marshfield Clinic Stevens Point Center, Stevens Point

57105

Avera Cancer Institute, Sioux Falls

57701

Rapid City Regional Hospital, Rapid City

59101

Billings Clinic Cancer Center, Billings

60134

Northwestern Medicine Cancer Center Delnor, Geneva

60555

Northwestern Medicine Cancer Center Warrenville, Warrenville

62269

Cancer Care Center of O'Fallon, O'Fallon

62401

Crossroads Cancer Center, Effingham

62526

Cancer Care Specialists of Illinois - Decatur, Decatur

Decatur Memorial Hospital, Decatur

65401

Delbert Day Cancer Institute at PCRMC, Rolla

68114

Nebraska Methodist Hospital, Omaha

73104

University of Oklahoma Health Sciences Center, Oklahoma City

74146

Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa

75235

Parkland Memorial Hospital, Dallas

75390

UT Southwestern/Simmons Cancer Center-Dallas, Dallas

87102

University of New Mexico Cancer Center, Albuquerque

87106

Southwest Gynecologic Oncology Associates Inc, Albuquerque

88011

Memorial Medical Center - Las Cruces, Las Cruces

97210

Legacy Good Samaritan Hospital and Medical Center, Portland

06520

Yale University, New Haven

01199

Baystate Medical Center, Springfield

02905

Women and Infants Hospital, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NRG Oncology

OTHER